- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide,
Total 1122 results
-
David Rizzieri, MDGenzyme, a Sanofi Company; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedPain | Advanced CancerUnited States
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsRecruitingFollicular Lymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
Peking Union Medical College HospitalRecruitingPrimary Intraocular LymphomaChina
-
University Hospital, ToulouseRecruiting
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Fondazione EMN Italy OnlusCompleted
-
CelgeneCompletedMultiple MyelomaFrance, Italy, Spain, Belgium, Greece
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingDLBCL | Untreated | MYC Gene RearrangementChina
-
Fondazione EMN Italy OnlusActive, not recruitingMultiple Myeloma | Newly Diagnosed PatientsItaly
-
University of BolognaTerminated
-
Samsung Medical CenterRecruiting
-
Marcelo Pasquini, MDNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruiting
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
University of Heidelberg Medical CenterActive, not recruiting
-
University of California, San DiegoCelgene CorporationWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Istituto Clinico HumanitasUnknown
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
Peking Union Medical College HospitalCelgene CorporationCompleted
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Follicular LymphomaUnited States, Korea, Republic of, Taiwan, China, Spain, United Kingdom, Australia, France, Germany, Japan, Turkey, Brazil, Poland, Ukraine, Italy, Russian Federation
-
RenJi HospitalRecruitingOverall Survival | Progression Free Survival | MaintenanceChina
-
University of CologneIncyte CorporationNot yet recruitingNon-Hodgkin LymphomaGermany
-
Juan DuRecruitingMultiple MyelomaChina
-
James RubensteinGenentech, Inc.; CelgeneCompletedIntraocular Lymphoma | Recurrent/Refractory CNSUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI); Celgene CorporationCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedLeukemiaUnited States
-
Institut Paoli-CalmettesCompletedNon-Hodgkin LymphomaFrance
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Robert Dreicer MDNational Cancer Institute (NCI)Completed
-
CelgeneCompletedMultiple MyelomaUnited States
-
CelgeneCompleted
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Seoul National University Bundang HospitalSamyang BioPharmRecruitingCentral Nervous System LymphomaKorea, Republic of
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
Mikkael Sekeres MDNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AG; Celgene CorporationCompletedLeukemia, Lymphocytic, Chronic, B-CellAustria
-
Medical University InnsbruckCelgene Corporation; Innsbruck - Tyrolean Working Group of Experimental Oncology...Unknown
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States